Egrifta SV

Adult Dosing .

Dosage forms:  INJ: 2 mg per vial

Special Note

[formulation clarification]

Info: tesamorelin products not interchangeable; do not substitute on a mg to mg basis

abdominal lipodystrophy, HIV-associated

[1.4 mg SC qd]

renal dosing

[not defined]

renal impairment: not defined

HD/PD: not defined

hepatic impairment

[not defined]

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.